Risk factors for fellow eye treatment in protocol T.
Steven NessMichael GreenDean LoporchioAlexander D PortXuejing ChenNicole H SiegelVasiliki PoulakiManju L SubramanianPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)
Bilateral treatment with intravitreal anti-VEGF injections was common during the DRCR.net Protocol T. Medication choice may impact the risk of fellow eye treatment.